Live Breaking News & Updates on Single cell dispenser

Stay updated with breaking news from Single cell dispenser. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Silver Sponsor Molecular Devices at Society for Laboratory Automation and Screening 2023 International Conference and Exhibition

SAN JOSE, Calif. (PRWEB) February 22, 2023 -- Molecular Devices, LLC., a leading provider of high-performance life science solutions, is demonstrating its

California , United-states , San-diego , Susan-murphy , Society-for-laboratory-automation , Research-to-high-throughput-on , Image-analysis-software , Biosciences-ltd , Molecular-devices , Solutions-life-sciences , Corning-life-sciences , Cincinnati-children-hospital-medical-center

Molecular Devices partners with SEED Biosciences to exclusively offer DispenCell Single-Cell Dispenser, expanding leadership in cell line development

SAN JOSE, Calif. (PRWEB) February 07, 2023 -- Molecular Devices, LLC., a leading provider of high-performance life science solutions, has entered into a

California , United-states , Switzerland , Susan-murphy , Georges-muller , Biosciences-ltd , Molecular-devices , Dispencell-single-cell-dispenser , Single-cell-dispenser , Silicon-valley , Press-release ,

NAMOCELL HIGHLIGHTED IN NATURE PUBLICATION FOR EFFICIENT SINGLE CELL CLONING OF HUMAN PLURIPOTENT STEM CELLS

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the publication of a single-cell cloning workflow study using the Namocell™ Single Cell...

David-clair , Bio-techne-protein-sciences , Bio-techne-corporation , Single-cell-dispenser , Nature-protocols , Namocell-single-cell , Namocell-single-cell-dispenser , Fluorescence-activated-cell-sorting , Single-cell-dispensers , Will-geist , Protein-sciences , Vice-president

HepaTx, Namocell, and Takara Bio USA complete second phase of collaboration on single cell analysis for cell therapy to treat late-stage liver diseases

Share this article
Share this article
PALO ALTO, Calif., March 12, 2021 /PRNewswire/ -- HepaTx Corporation, Namocell Inc., and Takara Bio USA, Inc. (TBUSA) announced successful completion of the second phase of their collaboration on single cell analysis of hepatocyte-like cells (iHeps) differentiated from adipose tissue-derived stromal cells (ASCs) using Namocell's Single Cell Dispensers and Takara Bio's SMART-seq® kits to characterize HepaTx's novel cell therapies for liver disease. The results of the second phase demonstrated a 95% success rate in single cell isolation and library construction. Single cell RNA-seq showed distinct clusters of cells at various differentiation stages. The high reproducibility of results within sample groups will support development of novel cell therapies and validate production processes.

Takara-bio , Suvarna-gandlur , Eric-schuur , Jun-yu-lin , Namocell-inc , Takara-bio-inc , Twitter , Takara-bio-united-states-inc , Prnewswire-hepatx-corporation , Takara-bio-united-states , Single-cell-dispensers